Pill to treat COVID-19 could be available year's end, Pfizer CEO says
CBSN
Fending off COVID-19 and avoiding potential trips to the hospital could soon be as simple as taking a pill.
Pfizer CEO Albert Bourla told CNBC on Tuesday that the drugmaker is working to introduce an experimental drug to treat the disease at its onset by year-end. Pfizer in March began an early-stage clinical trial of a new antiviral therapy for the coronavirus, which has killed more than 573,000 Americans. The drug could potentially be prescribed "at the first sign of infection, without requiring that patients are hospitalized or in critical care," Dr. Mikael Dolsten, chief scientific officer and president, worldwide research, development and medical of Pfizer, stated last month. Part of a group of medicines called protease inhibitors, which are used to treat HIV and Hepatitis C, the drug curbs production of enzymes needed for the virus to multiply in human cells.Child care in the U.S. today can cost more than families pay for rent, a mortgage or college tuition
The soaring cost of child care in the U.S. can now exceed what families pay for housing or college.
Mexico suggests it could retaliate with tariffs after Trump threat: "There is no subordination here"
President Claudia Sheinbaum suggested Tuesday that Mexico could retaliate ———with tariffs of its own, after U.S. President-elect Donald Trump threatened to impose 25% import duties on Mexican goods if the country doesn't stop the flow of drugs and migrants across the border.
A special agent at the Federal Bureau of Investigation has been charged with sexually assaulting two women, according to police and court records. The agent, Eduardo Valdivia, was previously acquitted of attempted murder for shooting a man on a Metro subway train near Washington, D.C., four years ago. He was arrested in Maryland on Monday.